Journal of Microbial & Biochemical Technology

Mahmoud Ghannoum

Biography

Dr. Ghannoum is a tenured Professor and Director of the Center for Medical Mycology at Case Western Reserve University and University Hospitals Medical Center. He is a Fellow of the Infectious Disease Society of America, and served as a President of the Medical Mycological Society of the Americas. He received the Freedom to Discover Award from Bristol-Myers Squibb for his expertise in the field of fungal biofilms, and the Billy Cooper Award from the Mycological Societies of the Americas for his contribution to the field of clinical mycology. Dr. Ghannoum was recently named one of the Most Interesting People in Cleveland, by Cleveland magazine for 2013.  He published nearly 250 peer reviewed articles in the field of biofilms, microbial pathogenesis and preclinical in vitro and in vivo evaluations of antimicrobials. Recently, he published the first study describing the oral mycobiome of healthy individuals. The center of excellence that Dr. Ghannoum directs is a multidisciplinary center that combines basic and translational research investigating fungi from the test tube to the bedside.  In 2009, he was appointed as the Chairman of the Subcommittee on Antifungal Susceptibility Testing, Clinical Laboratory Standards Institute. In 2013, he was appointed as an Advisor to the CLSI Consensus Microbiology Committee. Dr. Ghannoum has been involved in preclinical and clinical studies evaluating the efficacy of antifungals. He has in-depth interest and expertise in oral complications of HIV/AIDS, particularly oral candidiasis, and is currently the Chair of the Oral HIV-AIDS Research Alliance (OHARA) and is the PI of OHARA’s Medical Mycology Unit based at Case. He has acted as a consultant for pharmaceutical/Biotech industry and serve on advisory boards for various sponsors where he provide guidance regarding strategies for development of their potential anti-infectives that is in concordance with regulatory bodies.

Research Interest

Clinical Trials,In Vivo,Cell Biology,Pharmaceutical Industry,Translational Research,Immunology,Cell